On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:
Sponsors:
Audius (with CEO Roneil Rumberg)
Special drop: David on Levels' Podcast!
Explaining Macroeconomics, The Fed, Interest Rates and Valuations (with Matt McBrady)
Kim-Mai Cutler -- From Journalist to VC
Managing a Crypto Fund (with Kyle Samani from Multicoin Capital)
Owning Your Own Media Stream (from Collison Conf with Garry Tan)
Making your customers your secret weapon (with Highspot's Oliver Sharp)
LP "Expert Call" with Josh Clemente from Levels
The Meituan Bear Case (with Lillian Li)
Modern Treasury interviews Ben & David (and vice versa!)
State-of-SaaS and Deep Collaboration (with Jake Saper from Emergence Capital)
The Idea Dinner #1 (with Mario Gabriele and Packy McCormick)
Roblox IPO Preview (with Mario Gabriele from The Generalist)
What Remote Work Looks Like in 2021 (and Beyond) with Doist CEO Amir Salihefendić
VC Fundamentals Part 4: Portfolio Construction & Management (with Jaclyn Hester & Lindel Eakman of Foundry Group)
Masterclass: Superhuman's Fundraising Playbook (with CEO Rahul Vohra)
Book Club Discussion: Brotopia with Emily Chang
How YC Rewrote the Seed Playbook with Garry Tan
VC Fundamentals Part 3: Company Building
The Outsiders Book Club Discussion with author Will Thorndike
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Organic Marketing Simplified: Master podcast marketing, fuel podcast growth, and make money podcasting!
THE GO BIZ GUY
The Sigma Femme Podcast
The Prof G Pod with Scott Galloway
The Tim Ferriss Show